N/A
Completed N=101
A Professional Development Programme (ProDeveloP) for Newly Graduated Nurses
Professional Fulfillment · Professional Identity Formation · Professional Quality of Life · Support Program
Source: ClinicalTrials.gov NCT06742047 ↗
Enrolled (actual)
101
Serious AEs
0.0%
Results posted
Mar 2026
Primary outcomePrimary: Role Clarity — 9; 9 scores on a scale
Summary
This clinical study aims to implement and evaluate a professional development programme (ProDeveloP) designed to facilitate the transition of newly graduated nurses (NGNs) into their new roles. NGNs face several challenges in the work environment and in developing their professional competencies. The aim is to support NGNs in a county hospital in central Sweden to facilitate their professional development. Data will be collected during the NGNs' first year through measures at week week 13 (for both arms) and quarterly (intervention grpoup). This will be combined with individual interviews and focus groups with NGNs, dialogue facilitators and managers.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Role Clarity |
9; 9 | — |
| PRIMARY Task Mastery |
6; 6 | — |
| PRIMARY Social Acceptance |
6.5; 7 | — |
| PRIMARY Stress |
5; 7 | — |
| SECONDARY Job Satiscation |
— | — |
| SECONDARY Intentions to Leave |
— | — |
| SECONDARY Recovery |
— | — |
Eligibility Criteria
Inclusion criteria
- Registered nurses in Sweden employed as Newly Graduated Nurses (NGNs) in a county in central Sweden participating in the ProDeveloP, the intervention group.
- Registered nurses in Sweden employed as Newly Graduated Nurses (NGNs) in a county in central Sweden, NGNs participating in the introduction programme prior to the study, not participating in the ProDeveloP, the control group.
- Experienced registered nurses as facilitators for the dialogue groups for the NGNs in the intervention.
- Managers at the county hospital for the NGNs participating in the intervention.
Exclusion criteria
- Managers without NGNs participated in the intervention.
Data sourced from ClinicalTrials.gov (NCT06742047). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.